SCHEMBL19997530

SCHEMBL19997530

CC(C)NCNC(=S)NC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 3/20 0.38
EPHX1 P07099 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
QPCT Q16769 1/20 0.34
GAA P10253 2/20 0.33
RECQL P46063 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19849695 0.76 MEN1 (0.55) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL22364147 0.76 QPCT (0.37) MEN1KMT2AALDH1A1QPCTMAPKAPK2
SCHEMBL6209344 0.72 MEN1 (0.50) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL6208095 0.72 MEN1 (0.50) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL11504339 0.70 ALDH1A1 (0.60) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL2833590 0.70 MEN1 (0.60) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL14489950 0.69 MEN1 (0.57) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL1276388 0.68 MEN1 (1.00) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL11311904 0.67 KMT2A (0.55) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL10907938 0.67 KMT2A (0.55) MEN1KMT2ARAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10753942-B2 Methods to detect remnant cancer cells INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2020-08-25 US disclosed
US-20190107543-A1 METHODS TO DETECT REMNANT CANCER CELLS INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2019-04-11 US disclosed
US-10239891-B2 Compositions to detect remnant cancer cells INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2019-03-26 US disclosed
US-9926334-B1 2018-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239891-B2 Compositions to detect remnant cancer cells MKI67, TP53, RNASE1 MEN1 1389/4885KMT2A 3104/4885RAB9A 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.